No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Category: MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Discover Reeva FT: Revolutionizing Wound...

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Summus Medical Laser | Launches...

The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.

Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Summus Medical Laser | Launches Real-World Evidence Program

The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.

Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.

RTsafe and ZAP Surgical Forge Strategic Partnership to Promote the Latest Advances in Cranial Radiosurgery

Evangelos Pappas, Founder of RTsafe, expressed his enthusiasm for the collaboration, stating, "We are thrilled to join forces with ZAP Surgical in this transformative endeavour. By harnessing the power of our advanced phantom technology, we aim to elevate the standard of care in cranial radiosurgery and to highlight the unparalleled value of the ZAP-X platform”.

Paragonix Technologies Announces Commercial Availability of the FDA-cleared BAROguard™ Donor Lung Preservation System Nationwide

First-of-its-kind, the novel BAROguard system combines clinically proven hypothermic preservation techniques alongside active airway management control to ensure that donor lungs maintain optimal conditions during transport for maximum protection. Equipped with built-in tracking and real-time reporting, the device provides surgeons and transplant teams with continuous data on the organ's condition throughout transit.

Advancing Healthcare Energy: Olympus Awarded PROVISTA Contract

This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the POWERSEAL™ sealer/divider, the SONICBEAT™ ultrasonic portfolio and THUNDERBEAT™ hybrid energy portfolio.

Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device

"We're eager to collaborate with Laborie, pioneers in diagnostic and therapeutic urologic healthcare," said iO Urology Co-Founder and CEO Britton Garrett. "CarePath bridges the clinic-patient gap, offering a convenient, accessible solution for managing urological conditions in the home."

Baird Medical Devices Granted New Class III Certificate by China’s NMPA for Ceramic Thyroid Ablation Needle

"The introduction of the Ceramic Thyroid Ablation Needle signifies another breakthrough innovation in the field of microwave ablation and is a testament to our ongoing commitment to innovation and research," said Ms. Haimei Wu, Founder and CEO of Baird Medical. "We eagerly anticipate the positive impact of this technology by enhancing the patient treatment experiences and saving lives in the years to come."

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access

By using this website you agree to accept Medical Device News Magazine Privacy Policy